A multicentre, double-blind, randomised, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily without titration in patients with refractory epilepsy. - Betts,T.; Waegemans,T.; Crawford,P. (Seizure, 2000)